) and the effective delivery of chemotherapy within the tumour. As this mechanism may be relevant in a number of malignant tumours, Roche and Genentech are presently investigating the potential clinical benefit of the use of Avastin in a number of other forms of cancer, including non-small cell lung cancer, pancreatic, breast and renal cell carcinoma. Large clinical trials are also underway in patients with colorectal cancer that has not spread (adjuvant therapy).
In 2000, colorectal cancer was the third most commonly reported cancer with 945,000 new cases worldwide. It is estimated that over 50% of people diagnosed with colorectal cancer will die of the disease, and it is the most common cancer in developed countries1.
Roche in Oncology
Within the last five years Roche has become the world's leading provider of anti-cancer treatments, supportive care products and diagnostics. Its oncology business includes an unprecedented three marketed products with survival benefit; Herceptin, MabThera and Xeloda, treating a range of malignancies - breast cancer, non-Hodgkin's lymphoma and colorectal cancer. Other key products include NeoRecormon (anaemia in various cancer settings), Bondronat (prevention of skeletal events in breast cancer and bone metastases patients, hypercalcemia of malignancy), Kytril (chemotherapy and radiotherapy-induced nausea and vomiting) and Roferon-A (leukaemia, Kaposi's sarcoma, malignant melanoma, renal cell carcinoma). Roche's cancer medicines generated sales of more than 6 billion Swiss francs in 2003.
Roche is developing new tests which will have a significant impact on disease management for cancer patients in the future. With a broad portfolio of tumour markers for prostate, colorectal, liver, ovarian, breast, stomach, pancreas and lung cancer, as well as a range of molecular oncology tests, we will continue to be the leaders in providing cancer focused treatments and diagnostics.
Roche Oncology has fPage: 1 2 3 Related medicine news :1
Contact: Anna Korving
. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients2
. Breakthrough therapies treat Crohns disease3
. Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy4
. Breakthrough in hormonal breast cancer therapy5
. Breakthrough! UNC scientists research promises improved X-ray machines using carbon nanotubes6
. Breakthrough pain in cancer associated with need for increased medical services, higher medical costs7
. Simple test predicts ability to grow new blood vessels: Breakthrough in battle against heart disease, diabetes, cancer8
. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia9
. Low-Tech Treatment Proves A Life-Saver In Research Breakthrough10
. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain11
. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine